Cannabis, THC, CBD & Hemp Regulations in Eswatini: Complete 2026 Guide
Last updated: September 2026 Eswatini maintains a comprehensive prohibition on cannabis under colonial-era legislation. A reform process is underway to create a licensed pathway for medicinal and industrial uses, and limited industrial-hemp research trials have been authorised, but commercial medical or industrial cultivation is not yet legal. This guide summarises the current legal position as of 2026, including the status of the pending Cannabis Bill, CBD treatment, research activity and practical advice for residents, investors and travellers.Legal Status Overview (2026)
- Recreational cannabis: Fully illegal
- Medical cannabis: Not yet operational – reform legislation tabled but not enacted
- Industrial hemp: Research trials authorised only; commercial cultivation not yet legal
- CBD: Illegal – treated as a cannabis derivative with no exemption
- Personal / unlicensed possession: Criminal offence
Recreational Cannabis: Complete Prohibition
Possession, use, cultivation, sale and trafficking of cannabis remain criminal offences. There is no adult-use market, no personal-use exemption and no home-grow allowance. Informal cultivation and use have historically occurred (locally referred to as dagga), but the formal legal position is absolute prohibition. Government eradication activity (including spraying) has been reported and has drawn criticism from local cannabis associations seeking clearer policy and consultation.Medical Cannabis and the Pending Reform
There is currently no operational public medical-cannabis programme or patient-access system. Policy discussion and legislative drafting have focused on creating a licensed medicinal and industrial framework. The draft reform aims to distinguish lower-THC material for medical and industrial use from higher-THC varieties. Until the Cannabis Bill is passed and regulations are in place, medical cannabis remains outside the law for ordinary patients and commercial operators. Foreign medical prescriptions have no reliable legal recognition for importation or personal use.Industrial Hemp Research Trials
The Ministry of Agriculture has authorised limited research trials (approximately four hectares) coordinated with the University of Eswatini and private partners. The trials are designed to evaluate varieties, production costs, water requirements, pest and disease pressures, fibre and seed yields, processing requirements and potential markets under Eswatini’s conditions. Authorisation is strictly for research; any broader commercial cultivation programme depends on trial results, further government approvals and the enactment of an appropriate regulatory framework. Presentations on the industrial-hemp project have been made to His Majesty King Mswati III, and government interest in economic diversification is evident. Commercial licensing is not yet available.THC, CBD and Hemp Status
- CBD: Illegal. The 1922 Act does not distinguish CBD from other cannabis derivatives. The Ministry of Health and Pharmacy Council have not authorised CBD as a medicine, food supplement or cosmetic. Pharmacies do not legally stock CBD products. Imports of CBD oils, tinctures, topicals or similar items are treated as controlled cannabis derivatives and face seizure at customs.
- Industrial hemp: Not commercially legal. Limited research trials are authorised. Commercial cultivation, processing or sale of hemp fibre, seed or related products awaits the new legal framework and further approvals. No statutory low-THC threshold currently exempts hemp from the general prohibition.
Penalties for Violations
Unauthorised possession, use, cultivation, sale and trafficking of cannabis are criminal offences under the Opium and Habit-Forming Drugs Act and related legislation. Penalties can include imprisonment and fines; exact sentencing depends on the nature and scale of the offence. Travellers should treat any involvement with cannabis or CBD products as high-risk. Enforcement practice can vary, but the formal legal position is prohibition.Practical Reality for Travellers, Residents and Investors
Bringing cannabis, CBD products or related materials into Eswatini — even if legal or prescribed elsewhere — carries a high risk of seizure, arrest and prosecution. There is currently no reliable medical exception for travellers. Informal availability does not equal legality. Investors and commercial operators interested in medicinal or industrial cannabis must wait for the Cannabis Bill to be enacted and for clear licensing regulations to be issued. Research-trial authorisation does not constitute commercial permission. Anyone following the reform process should treat any future change as prospective only until legislation is passed, gazetted and operational.Comparison with Neighbouring / Regional Countries (2026 Snapshot)
| Country | Recreational | Medical / Industrial | CBD / Hemp Notes |
|---|---|---|---|
| Eswatini | Illegal | Pending legislation; research trials only | CBD illegal; commercial hemp not yet legal |
| Botswana | Illegal | Licensed (Cannabis Act 2025; industrial ≤ 0.7% THC) | Tightly regulated; no open CBD retail |
| South Africa | Private adult use limited | Limited framework | CBD under dosage rules |
| Lesotho | Illegal | Licensed medical/industrial | Export-oriented licensing |
| Zimbabwe | Illegal | Licensed medical/industrial | Export-oriented licensing |
| Malawi | Illegal | Licensed (CRA; industrial ≤ 1% THC) | Licensed medical & industrial pathway |
